Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Henry Gewirtz, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Dilsizian V, Gewirtz H, Marwick TH, Kwong RY, Raggi P, Al-Mallah MH, Herzog CA. Cardiac Imaging for Coronary Heart Disease Risk Stratification in Chronic Kidney Disease. JACC Cardiovasc Imaging. 2020 Aug 19. PMID: 32828780.
    Citations:    
  2. Gewirtz H, Narula J. A Closer Look at 18Flurpiridaz Data in IHD: Hiding in Plain Sight. J Am Coll Cardiol. 2020 Jul 28; 76(4):402-404. PMID: 32703510.
    Citations:    
  3. Gewirtz H. PET 18F-flurpridaz quantitative measurements of myocardial blood flow: Added value for diagnosis of coronary artery disease? Of course! J Nucl Cardiol. 2020 Feb 04. PMID: 32020502.
    Citations:    
  4. Gewirtz H, Iskandrian AE, Morgan C, Schelbert HR. Positron-Emission Tomography Quantitative Measurements of Myocardial Blood Flow: Just the Facts…. JACC Cardiovasc Imaging. 2019 09; 12(9):1864-1867. PMID: 31488254.
    Citations:    
  5. Gewirtz H. CMR quantitative measurements of myocardial blood flow: Not ready for routine clinical application. J Nucl Cardiol. 2019 Jul 17. PMID: 31317327.
    Citations:    
  6. Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P, Cerqueira MD, deKemp RA, DePuey EG, Dilsizian V, Dorbala S, Ficaro EP, Garcia EV, Gewirtz H, Heller GV, Lewin HC, Malhotra S, Mann A, Ruddy TD, Schindler TH, Schwartz RG, Slomka PJ, Soman P, Di Carli MF. Correction to: Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Cardiol. 2018 Dec; 25(6):2189-2190. PMID: 29637524.
    Citations:    Fields:    
  7. Gewirtz H. Serial PET Measurements of Myocardial Blood Flow for Prognosis Assessment in Heart Transplant Patients: The Forest and the Trees. JACC Cardiovasc Imaging. 2020 01; 13(1 Pt 1):121-123. PMID: 30343076.
    Citations:    Fields:    
  8. Grupper A, Gewirtz H, Kushwaha S. Reinnervation post-heart transplantation. Eur Heart J. 2018 05 21; 39(20):1799-1806. PMID: 28087606.
    Citations: 2     Fields:    
  9. Gewirtz H. Coronary circulation: Pressure/flow parameters for assessment of ischemic heart disease. J Nucl Cardiol. 2019 04; 26(2):459-470. PMID: 29637523.
    Citations:    Fields:    
  10. Gewirtz H. Tight software, methodological/physiological variation, less so. J Nucl Cardiol. 2018 12; 25(6):1926-1928. PMID: 29453602.
    Citations:    
  11. Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P, Cerqueira MD, deKemp RA, DePuey EG, Dilsizian V, Dorbala S, Ficaro EP, Garcia EV, Gewirtz H, Heller GV, Lewin HC, Malhotra S, Mann A, Ruddy TD, Schindler TH, Schwartz RG, Slomka PJ, Soman P, Di Carli MF, Einstein A, Russell R, Corbett JR. Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Cardiol. 2018 Feb; 25(1):269-297. PMID: 29243073.
    Citations:    Fields:    
  12. Krishnan S, Venn R, Blumenthal DM, Bhambhani V, Gewirtz H, Weiner RB, Nagurney JT, Wasfy JH. Utilization of stress testing for low-risk patients with chest discomfort in the emergency department. J Nucl Cardiol. 2019 10; 26(5):1642-1646. PMID: 29374373.
    Citations:    Fields:    
  13. Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P, Cerqueira MD, deKemp RA, DePuey EG, Dilsizian V, Dorbala S, Ficaro EP, Garcia EV, Gewirtz H, Heller GV, Lewin HC, Malhotra S, Mann A, Ruddy TD, Schindler TH, Schwartz RG, Slomka PJ, Soman P, Di Carli MF. Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Med. 2018 02; 59(2):273-293. PMID: 29242396.
    Citations: 1     Fields:    
  14. Secemsky EA, Gallagher R, Harkness J, Pomerantsev E, Gewirtz H, Jaffer FA, Yeh RW. Target Vessel Revascularization and Territory of Myocardial Ischemia in Patients With Chronic Total Occlusions. J Am Coll Cardiol. 2017 08 29; 70(9):1196-1197. PMID: 28838371.
    Citations: 2     Fields:    
  15. Gewirtz H. PET measurements of myocardial blood flow post myocardial infarction: Relationship to invasive and cardiac magnetic resonance studies and potential clinical applications. J Nucl Cardiol. 2017 12; 24(6):1883-1892. PMID: 28577226.
    Citations:    Fields:    Translation:Humans
  16. Gewirtz H, Dilsizian V. Myocardial Viability: Survival Mechanisms and Molecular Imaging Targets in Acute and Chronic Ischemia. Circ Res. 2017 Mar 31; 120(7):1197-1212. PMID: 28360350.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  17. Gewirtz H, Dilsizian V. Defining Inflammatory Levels of Carotid Artery and Aortic 18FDG Uptake: Implications for Clinical Trial Design and Individual Patient Management. JACC Cardiovasc Imaging. 2016 10; 9(10):1208-1210. PMID: 27639758.
    Citations:    Fields:    Translation:Humans
  18. Gewirtz H, Dilsizian V. Integration of Quantitative Positron Emission Tomography Absolute Myocardial Blood Flow Measurements in the Clinical Management of Coronary Artery Disease. Circulation. 2016 May 31; 133(22):2180-96. PMID: 27245647.
    Citations: 7     Fields:    Translation:HumansAnimals
  19. Gewirtz H. Functional Versus Anatomic Imaging of CAD: Lessons Learned from Recent Clinical Trials. Curr Cardiol Rep. 2016 Jan; 18(1):4. PMID: 26699631.
    Citations:    Fields:    Translation:Humans
  20. Gewirtz H. SPECT Myocardial Perfusion Imaging: Poststress, End Systolic Images and the Ongoing Effort to Improve Diagnostic Accuracy. J Nucl Med. 2015 Dec; 56(12):1813-4. PMID: 26315833.
    Citations:    Fields:    Translation:Humans
  21. Dilsizian V, Gewirtz H, Paivanas N, Kitsiou AN, Hage FG, Crone NE, Schwartz RG. Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies. J Nucl Cardiol. 2015 Dec; 22(6):1198-213; quiz 1195-7. PMID: 25975944.
    Citations: 13     Fields:    Translation:Humans
  22. Cheezum MK, Subramaniyam PS, Bittencourt MS, Hulten EA, Ghoshhajra BB, Shah NR, Forman DE, Hainer J, Leavitt M, Padmanabhan R, Skali H, Dorbala S, Hoffmann U, Abbara S, Di Carli MF, Gewirtz H, Blankstein R. Prognostic value of coronary CTA vs. exercise treadmill testing: results from the Partners registry. Eur Heart J Cardiovasc Imaging. 2015 Dec; 16(12):1338-46. PMID: 25899714.
    Citations: 4     Fields:    Translation:Humans
  23. Gewirtz H. How close is close enough? JACC Cardiovasc Imaging. 2014 Nov; 7(11):1128-9. PMID: 25459594.
    Citations:    Fields:    Translation:Humans
  24. Truong QA, Gewirtz H. Cardiac PET-CT for monitoring medical and interventional therapy in patients with CAD: PET alone versus hybrid PET-CT? Curr Cardiol Rep. 2014 Mar; 16(3):460. PMID: 24464305.
    Citations: 1     Fields:    Translation:Humans
  25. Bose A, Kandala J, Upadhyay GA, Riedl L, Ahmado I, Padmanabhan R, Gewirtz H, Mulligan LJ, Singh JP. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2014 May; 25(5):507-513. PMID: 24350650.
    Citations: 8     Fields:    Translation:Humans
  26. Gould KL, Johnson NP, Bateman TM, Beanlands RS, Bengel FM, Bober R, Camici PG, Cerqueira MD, Chow BJW, Di Carli MF, Dorbala S, Gewirtz H, Gropler RJ, Kaufmann PA, Knaapen P, Knuuti J, Merhige ME, Rentrop KP, Ruddy TD, Schelbert HR, Schindler TH, Schwaiger M, Sdringola S, Vitarello J, Williams KA, Gordon D, Dilsizian V, Narula J. Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol. 2013 Oct 29; 62(18):1639-1653. PMID: 23954338.
    Citations: 90     Fields:    Translation:HumansAnimals
  27. Gewirtz H. Myocardial imaging for mitochondrial membrane potential. JACC Cardiovasc Imaging. 2012 Jul; 5(7):758-60; author reply 760-1. PMID: 22789946.
    Citations:    Fields:    Translation:HumansAnimalsCells
  28. D'Ascenzo F, Presutti DG, Picardi E, Moretti C, Omedè P, Sciuto F, Novara M, Yan AT, Goodman S, Mahajan N, Kosuge M, Palazzuoli A, Jong GP, Isma'eel H, Budoff MJ, Rubinshtein R, Gewirtz H, Reed MJ, Theroux P, Biondi-Zoccai G, Modena MG, Sheiban I, Gaita F. Prevalence and non-invasive predictors of left main or three-vessel coronary disease: evidence from a collaborative international meta-analysis including 22 740 patients. Heart. 2012 Jun; 98(12):914-9. PMID: 22626899.
    Citations: 6     Fields:    Translation:Humans
  29. Gewirtz H. PET measurement of adenosine stimulated absolute myocardial blood flow for physiological assessment of the coronary circulation. J Nucl Cardiol. 2012 Apr; 19(2):347-54. PMID: 22231036.
    Citations: 5     Fields:    Translation:Humans
  30. Gurm GS, Danik SB, Shoup TM, Weise S, Takahashi K, Laferrier S, Elmaleh DR, Gewirtz H. 4-[18F]-tetraphenylphosphonium as a PET tracer for myocardial mitochondrial membrane potential. JACC Cardiovasc Imaging. 2012 Mar; 5(3):285-92. PMID: 22421174.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  31. Gewirtz H. PET measurement of absolute myocardial blood flow and LV function in dilated cardiomyopathy. JACC Cardiovasc Imaging. 2011 May; 4(5):557-60. PMID: 21565745.
    Citations: 3     Fields:    Translation:Humans
  32. Gewirtz H. Quantitative PET measurements of myocardial blood flow in young, healthy volunteers what should we expect? JACC Cardiovasc Imaging. 2011 Apr; 4(4):413-5. PMID: 21492817.
    Citations:    Fields:    Translation:Humans
  33. Gewirtz H. Cardiac PET: a versatile, quantitative measurement tool for heart failure management. JACC Cardiovasc Imaging. 2011 Mar; 4(3):292-302. PMID: 21414579.
    Citations: 4     Fields:    Translation:Humans
  34. Uthamalingam S, Zheng H, Leavitt M, Pomerantsev E, Ahmado I, Gurm GS, Gewirtz H. Exercise-induced ST-segment elevation in ECG lead aVR is a useful indicator of significant left main or ostial LAD coronary artery stenosis. JACC Cardiovasc Imaging. 2011 Feb; 4(2):176-86. PMID: 21329903.
    Citations: 8     Fields:    Translation:Humans
  35. Okada DR, Ghoshhajra BB, Blankstein R, Rocha-Filho JA, Shturman LD, Rogers IS, Bezerra HG, Sarwar A, Gewirtz H, Hoffmann U, Mamuya WS, Brady TJ, Cury RC. Direct comparison of rest and adenosine stress myocardial perfusion CT with rest and stress SPECT. J Nucl Cardiol. 2010 Jan-Feb; 17(1):27-37. PMID: 19936863.
    Citations: 26     Fields:    Translation:Humans
  36. Blankstein R, Shturman LD, Rogers IS, Rocha-Filho JA, Okada DR, Sarwar A, Soni AV, Bezerra H, Ghoshhajra BB, Petranovic M, Loureiro R, Feuchtner G, Gewirtz H, Hoffmann U, Mamuya WS, Brady TJ, Cury RC. Adenosine-induced stress myocardial perfusion imaging using dual-source cardiac computed tomography. J Am Coll Cardiol. 2009 Sep 15; 54(12):1072-84. PMID: 19744616.
    Citations: 106     Fields:    Translation:Humans
  37. Gewirtz H. 'Funny' current: if heart rate slowing is not the best answer, what might be? Cardiovasc Res. 2009 Oct 01; 84(1):9-10. PMID: 19617225.
    Citations: 1     Fields:    Translation:Animals
  38. Hajjiri MM, Leavitt MB, Zheng H, Spooner AE, Fischman AJ, Gewirtz H. Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. JACC Cardiovasc Imaging. 2009 Jun; 2(6):751-8. PMID: 19520347.
    Citations: 48     Fields:    Translation:Humans
  39. Gewirtz H. Regulating myocardial blood flow in health and disease. Curr Cardiol Rep. 2009 Mar; 11(2):117-24. PMID: 19236827.
    Citations:    Fields:    Translation:Humans
  40. Akutsu Y, Gregory SA, Kardan A, Zervos GD, Thomas GS, Gewirtz H, Yasuda T. Delayed heart rate recovery after adenosine stress testing with supplemental arm exercise predicts mortality. J Nucl Cardiol. 2009 Jan-Feb; 16(1):54-62. PMID: 19152129.
    Citations: 1     Fields:    Translation:Humans
  41. Jones SE, Aziz K, Yasuda T, Gewirtz H, Scott JA. Importance of systematic review of rotating projection images from Tc99m-sestamibi cardiac perfusion imaging for noncardiac findings. Nucl Med Commun. 2008 Jul; 29(7):607-13. PMID: 18528182.
    Citations: 5     Fields:    Translation:Humans
  42. Gregory SA, MacRae CA, Aziz K, Sims KB, Schmahmann JD, Kardan A, Morss AM, Ellinor PT, Tawakol A, Fischman AJ, Gewirtz H. Myocardial blood flow and oxygen consumption in patients with Friedreich's ataxia prior to the onset of cardiomyopathy. Coron Artery Dis. 2007 Feb; 18(1):15-22. PMID: 17172925.
    Citations: 6     Fields:    Translation:Humans
  43. Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, Yates D, LaMuraglia GM, Furie K, Houser S, Gewirtz H, Muller JE, Brady TJ, Fischman AJ. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006 Nov 07; 48(9):1818-24. PMID: 17084256.
    Citations: 210     Fields:    Translation:HumansCells
  44. Tawakol A, Aziz K, Migrino R, Watkowska J, Zusman R, Alpert NM, Fischman AJ, Gewirtz H. Effects of sildenafil on myocardial blood flow in humans with ischemic heart disease. Coron Artery Dis. 2005 Nov; 16(7):443-9. PMID: 16205453.
    Citations: 1     Fields:    Translation:Humans
  45. Gewirtz H. Letter regarding article by Kaufmann et al, "systemic inhibition of nitric oxide synthase unmasks neural constraint of maximal myocardial blood flow in humans". Circulation. 2005 May 03; 111(17):e278-9; author reply e278-9. PMID: 15867190.
    Citations: 1     Fields:    Translation:Humans
  46. Tawakol A, Migrino RQ, Hoffmann U, Abbara S, Houser S, Gewirtz H, Muller JE, Brady TJ, Fischman AJ. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol. 2005 May-Jun; 12(3):294-301. PMID: 15944534.
    Citations: 87     Fields:    Translation:Animals
  47. Tawakol A, Migrino RQ, Aziz KS, Waitkowska J, Holmvang G, Alpert NM, Muller JE, Fischman AJ, Gewirtz H. High-dose folic acid acutely improves coronary vasodilator function in patients with coronary artery disease. J Am Coll Cardiol. 2005 May 17; 45(10):1580-4. PMID: 15893170.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  48. Scott JA, Aziz K, Yasuda T, Gewirtz H. Integration of clinical and imaging data to predict the presence of coronary artery disease with the use of neural networks. Coron Artery Dis. 2004 Nov; 15(7):427-34. PMID: 15492592.
    Citations: 3     Fields:    Translation:Humans
  49. Tawakol A, Sims K, MacRae C, Friedman JR, Alpert NM, Fischman AJ, Gewirtz H. Myocardial flow regulation in people with mitochondrial myopathy, encephalopathy, lactic acidosis, stroke-like episodes/myoclonic epilepsy and ragged red fibers and other mitochondrial syndromes. Coron Artery Dis. 2003 May; 14(3):197-205. PMID: 12702922.
    Citations: 1     Fields:    Translation:HumansCells
  50. Tawakol A, Forgione MA, Stuehlinger M, Alpert NM, Cooke JP, Loscalzo J, Fischman AJ, Creager MA, Gewirtz H. Homocysteine impairs coronary microvascular dilator function in humans. J Am Coll Cardiol. 2002 Sep 18; 40(6):1051-58. PMID: 12354427.
    Citations: 27     Fields:    Translation:HumansCTClinical Trials
  51. Gewirtz H, Tawakol A, Bacharach SL. Heterogeneity of myocardial blood flow and metabolism: review of physiologic principles and implications for radionuclide imaging of the heart. J Nucl Cardiol. 2002 Sep-Oct; 9(5):534-41. PMID: 12360134.
    Citations: 2     Fields:    Translation:Humans
  52. Tawakol A, Gewirtz H. Does CABG improve left ventricular ejection fraction in patients with ischemic cardiomyopathy, and does it matter? J Nucl Med. 2001 Jan; 42(1):87-90. PMID: 11197986.
    Citations: 1     Fields:    Translation:Humans
  53. Tawakol A, Skopicki HA, Abraham SA, Alpert NM, Fischman AJ, Picard MH, Gewirtz H. Evidence of reduced resting blood flow in viable myocardial regions with chronic asynergy. J Am Coll Cardiol. 2000 Dec; 36(7):2146-53. PMID: 11127454.
    Citations: 5     Fields:    Translation:Humans
  54. Holmvang G, Fry S, Skopicki HA, Abraham SA, Alpert NM, Fischman AJ, Picard MH, Gewirtz H. Relation between coronary "steal" and contractile function at rest in collateral-dependent myocardium of humans with ischemic heart disease. Circulation. 1999 May 18; 99(19):2510-6. PMID: 10330381.
    Citations: 6     Fields:    Translation:Humans
  55. Zervos G, Zusman RM, Swindle LA, Alpert NM, Fischman AJ, Gewirtz H. Effects of nifedipine on myocardial blood flow and systolic function in humans with ischemic heart disease. Coron Artery Dis. 1999 May; 10(3):185-94. PMID: 10352896.
    Citations: 1     Fields:    Translation:Humans
  56. Kushwaha SS, Narula J, Narula N, Zervos G, Semigran MJ, Fischman AJ, Alpert NA, Dec GW, Gewirtz H. Pattern of changes over time in myocardial blood flow and microvascular dilator capacity in patients with normally functioning cardiac allografts. Am J Cardiol. 1998 Dec 01; 82(11):1377-81. PMID: 9856923.
    Citations: 4     Fields:    Translation:Humans
  57. Huggins GS, Pasternak RC, Alpert NM, Fischman AJ, Gewirtz H. Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation. 1998 Sep 29; 98(13):1291-6. PMID: 9751677.
    Citations: 27     Fields:    Translation:Humans
  58. Beache GM, Kulke SF, Kantor HL, Niemi P, Campbell TA, Chesler DA, Gewirtz H, Rosen BR, Brady TJ, Weisskoff RM. Imaging perfusion deficits in ischemic heart disease with susceptibility-enhanced T2-weighted MRI: preliminary human studies. Magn Reson Imaging. 1998; 16(1):19-27. PMID: 9436943.
    Citations: 1     Fields:    Translation:Humans
  59. Skopicki HA, Abraham SA, Picard MH, Alpert NM, Fischman AJ, Gewirtz H. Effects of dobutamine at maximally tolerated dose on myocardial blood flow in humans with ischemic heart disease. Circulation. 1997 Nov 18; 96(10):3346-52. PMID: 9396426.
    Citations: 9     Fields:    Translation:Humans
  60. Gewirtz H, Skopicki HA, Abraham SA, Castano H, Dinsmore RE, Alpert NM, Fischman AJ. Quantitative PET measurements of regional myocardial blood flow: observations in humans with ischemic heart disease. Cardiology. 1997 Jan-Feb; 88(1):62-70. PMID: 8960628.
    Citations: 10     Fields:    Translation:HumansAnimals
  61. Skopicki HA, Abraham SA, Weissman NJ, Mukerjee AK, Alpert NM, Fischman AJ, Picard MH, Gewirtz H. Factors influencing regional myocardial contractile response to inotropic stimulation. Analysis in humans with stable ischemic heart disease. Circulation. 1996 Aug 15; 94(4):643-50. PMID: 8772683.
    Citations: 5     Fields:    Translation:Humans
  62. Gewirtz H. Myocardial hibernation: unresolved physiological and clinical issues. Basic Res Cardiol. 1995 Jan-Feb; 90(1):32-4. PMID: 7779054.
    Citations:    Fields:    Translation:HumansAnimals
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Gewirtz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (217)
Explore
_
Co-Authors (43)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.